TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/24/24 16:08 | 5/23/24 | IART | Integra Lifesciences Holdings Corp | DE | Health | MdEq | Surgical & Medical Instrument | Essig Stuart | NJ | DO | Exec. CB | P | 1,500 | 28.49 | 0 | 53 | 3 | 1,753 | D | ||||||||||||||
5/8/24 19:01 | 5/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Essig Stuart | ME | D | M.d | 0 | 0.00 | 0 | 0 | 15 | 2 | D | |||||||||||||||
5/15/23 17:31 | 5/11/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Essig Stuart | ME | D | M.d | 0 | 0.00 | 0 | 0 | 25 | 2 | D | |||||||||||||||
5/13/22 17:56 | 5/11/22 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Essig Stuart | ME | D | M.d | 0 | 0.00 | 0 | 0 | 19 | 1 | D | |||||||||||||||
1/5/22 09:14 | 1/4/22 | DYNT | Dynatronics Corp | UT | Health | MdEq | Surgical & Medical Instrument | Essig Stuart | TX | T | P | 0 | 0.00 | 0 | 80 | 4 | 1,993 | M | |||||||||||||||
10/5/21 16:25 | 10/4/21 | DYNT | Dynatronics Corp | UT | Health | MdEq | Surgical & Medical Instrument | Essig Stuart | TX | T | P | 0 | 0.00 | 0 | 52 | 3 | 1,813 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |